Celosome Mid with Lidocaine (1 x 1.1 mL) | ExoCoBio

Short Description

A balanced, versatile Hyaluronic Acid dermal filler formulated with 24 mg/mL of cross-linked HA, 0.3% lidocaine, and patented HENM (High concentration Equalized cross-linked Network Membrane) technology. Calibrated for mid-to-deep dermal placement and lip mucosal tissue, Celosome Mid delivers smooth volumetric correction, exceptional tissue integration, and natural dynamic flexibility for moderate-to-severe facial folds, lip contouring, and perioral rejuvenation lasting 9 to 12 months.

Detailed Description

Celosome Mid is a sterile, non-pyrogenic physiological cross-linked sodium hyaluronate injectable developed by ExoCoBio (South Korea). Engineered as the versatile core workhorse of the Celosome line, it balances lifting power ($G’$) and cohesive spreadability to treat tissue depressions without creating palpable firmness or visible borders.

Manufactured using proprietary HENM technology, Celosome Mid interlocks hyaluronic acid chains into a uniform, equalized 3D membrane network. Subjected to an exhaustive 8-stage membrane dialysis process, unreacted BDDE monomers and heavy chemical residues are reduced to undetectable levels, dramatically diminishing the likelihood of post-injection erythema, swelling, or delayed immune hypersensitivity. The resulting hydrogel flows smoothly into the mid-to-deep reticular dermis, moving synchronously with dynamic facial expressions while maintaining structural integrity against everyday muscle movement.

Treatment Areas & Indications

• Moderate-to-Severe Facial Folds & Depressions:

  • Moderate-to-deep nasolabial folds (smile lines running from the nasal ala to mouth angles)

  • Marionette lines and oral commissure softening

  • Glabellar lines and deep forehead furrows (when dermal filling is indicated)

• Lip Augmentation & Perioral Enhancement:

  • Full lip volume enhancement and mucosal plumping

  • Vermilion border sharpening and Cupid’s bow definition

  • Philtral column contouring and perioral line smoothing

• Midface & Cheek Softening:

  • Moderate cheek creases and accordion smile lines

  • Labiomental groove (mental crease between lower lip and chin) softening

  • Atrophic facial scar elevation

Key Clinical Advantages

• Patented HENM Balanced Viscoelasticity: Provides optimal shear resistance and cohesive fluidity, delivering smooth tissue filling that adapts naturally to high-mobility zones like the lips and perioral area.

• Ultra-Low BDDE & High Biocompatibility: Purified via an 8-stage dialysis filtration protocol that strips away residual cross-linkers, ensuring minimal post-treatment swelling, zero Tyndall effect, and patient tolerance.

• 10% Extra Volume (1.1 mL Syringe): Packed with 1.1 mL of hydrogel per syringe, offering clinicians a 10% volume advantage over standard 1.0 mL industry alternatives for more comprehensive full-treatment coverage.

• Integrated 0.3% Lidocaine: Formulated with lidocaine hydrochloride to numb the treatment plane during extrusion, ensuring patient comfort during sensitive perioral and lip procedures.

• Natural Dynamic Expression: Integrates directly between host dermal collagen fibers, preventing gel migration, nodule formation, or an unnatural, stiff appearance during speaking and smiling.

• Dependable Longevity: Highly resistant to free-radical shear and endogenous hyaluronidase, sustaining corrective results for 9 to 12 months.

Technical Specifications

Professional Advisory: Celosome Mid with Lidocaine is a medical-grade injectable device intended strictly for certified dermatologists, plastic surgeons, and credentialed aesthetic physicians skilled in mid-dermal and advanced lip injection techniques. Not authorized for superficial injection or non-clinical consumer use.